Cannabis Stocks Dive
Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
Alexander Malyshev and Sarah Ganley of Carter Ledyard & Milburn LLP discuss what the cannabis sector can expect as 2025 ...
A Drug Enforcement Administration (DEA) judge has ordered the agency to respond to new allegations that it opposes the Biden ...
Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...
The DEA rejected a September request from Colorado officials to participate in the United States' historic marijuana ...
Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence ...
Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling ...
The state's recreational cannabis industry has expanded to be one of the biggest cannabis markets in the country. Here's what 2025 will look like.
The latest announcement is out from Village Farms International ( (VFF) ).
Here are our cannabis industry predictions for 2025: The process to reclassify marijuana as a Schedule 3 drug must end ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback